Oral modified-release lozenges and their preparation method

Details for Australian Patent Application No. 2004318976 (hide)

Owner Lotus Pharmaceutical Co., Ltd.

Inventors Wang, Kuenjen; Lin, Tongho

Agent Shelston IP

Pub. Number AU-B-2004318976

PCT Pub. Number WO2005/105109

Filing date 29 April 2004

Wipo publication date 10 November 2005

Acceptance publication date 9 April 2009

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/105109 Priority application(s): WO2005/105109

9 April 2009 Application Accepted

  Published as AU-B-2004318976

6 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004318986-Cerebrum evaluation device

2004318974-Device for dynamic bone stabilization